Towards Healthcare
Non-Invasive Blood Glucose Monitoring System Market Size, Trends & Companies

Non-Invasive Blood Glucose Monitoring System Market Competitive Strategies

Based on market forecasts, the non-invasive blood glucose monitoring system sector will expand from USD 34 million in 2024 to USD 316.65 million by 2034, experiencing a CAGR of 25%. Non-invasive blood glucose monitors measure glucose levels without finger pricks, using technologies like spectroscopy and transdermal sensing. Rising diabetes cases, needlestick infections, tech advances (AI, IoT), an aging population, and supportive government policies are driving market growth.

Introduction

  • Research Objective
  • Scope of the Study
  • Definition and Taxonomy

Research Methodology

  • Research Approach
  • Data Sources
  • Assumptions

Executive Summary

  • Synopsis
  • Analyst Recommendations

Market Overview 

  • Market Dynamics
    • Market Drivers
    • Market Restraints
    • Market Opportunities
  • Value Chain Analysis
    • Raw Material Sourcing
    • Manufacturing Process
    • Logistics & Transportation
    • Buyer Preferences
  • Trends
    • Market Trends
    • Technological Trends
  • Porter’s Five Forces Analysis
    • Bargaining Power of Suppliers
    • Bargaining Power of Buyers
    • Threat of Substitute
    • Threat of New Entrants
    • Degree of Competition
  • PESTLE Analysis for 5 Leading Countries
    • Regulatory Framework for Leading Countries/Regions
    • Supply Demand Analysis
    • Production & Consumption Statistics
    • Export Import Statistics
    • Price Trend Analysis

Global Non-Invasive Blood Glucose Monitoring System Market Assessment

  • Overview
  • Global Non-Invasive Blood Glucose Monitoring System Market Size Value (US$) and Volume (Million Tons), by Technology (2021 – 2033)
    • Spectroscopy 
    • Electromagnetic 
    • Microwave 
    • Ultrasonic 
    • Thermal 
    • Others
  • Global Non-Invasive Blood Glucose Monitoring System Market Size Value (US$) and Volume (Million Tons), by End User (2021 – 2033)
    • Hospitals
    • Homecare
    • Clinics
  • Global Non-Invasive Blood Glucose Monitoring System Market Size Value (US$) and Volume (Million Tons), by Modality (2021 – 2033)
    • Non wearable
    • Wearable
    • Invasive
    • Non-invasive
  • Global Non-Invasive Blood Glucose Monitoring System Market Size Value (US$) and Volume (Million Tons), by Distribution Channel (2021 – 2033)
    • Retail Sales
    • Institutional Sales
  • Global Non-Invasive Blood Glucose Monitoring System Market Size Value (US$) and Volume (Million Tons), by Geography (2021 – 2033)
    • North America
    • Europe
    • Asia-Pacific
    • Latin America
    • Middle East & Africa (MEA)

North America Non-Invasive Blood Glucose Monitoring System Market Assessment

  • Overview
  • North America Non-Invasive Blood Glucose Monitoring System Market Size Value (US$) and Volume (Million Tons), by Technology (2021 – 2033)
    • Spectroscopy 
    • Electromagnetic 
    • Microwave 
    • Ultrasonic 
    • Thermal 
    • Others
  • North America Non-Invasive Blood Glucose Monitoring System Market Size Value (US$) and Volume (Million Tons), by End User (2021 – 2033)
    • Hospitals
    • Homecare
    • Clinics
  • North America Non-Invasive Blood Glucose Monitoring System Market Size Value (US$) and Volume (Million Tons), by Modality (2021 – 2033)
    • Non wearable
    • Wearable
    • Invasive
    • Non-invasive
  • North America Non-Invasive Blood Glucose Monitoring System Market Size Value (US$) and Volume (Million Tons), by Distribution Channel (2021 – 2033)
    • Retail Sales
    • Institutional Sales

Europe Non-Invasive Blood Glucose Monitoring System Market Assessment

  • Overview
  • Europe Non-Invasive Blood Glucose Monitoring System Market Size Value (US$) and Volume (Million Tons), by Technology (2021 – 2033)
    • Spectroscopy 
    • Electromagnetic 
    • Microwave 
    • Ultrasonic 
    • Thermal 
    • Others
  • Europe Non-Invasive Blood Glucose Monitoring System Market Size Value (US$) and Volume (Million Tons), by End User (2021 – 2033)
    • Hospitals
    • Homecare
    • Clinics
  • Europe Non-Invasive Blood Glucose Monitoring System Market Size Value (US$) and Volume (Million Tons), by Modality (2021 – 2033)
    • Non wearable
    • Wearable
    • Invasive
    • Non-invasive
  • Europe Non-Invasive Blood Glucose Monitoring System Market Size Value (US$) and Volume (Million Tons), by Distribution Channel (2021 – 2033)
    • Retail Sales
    • Institutional Sales

Asia-Pacific Non-Invasive Blood Glucose Monitoring System Market Assessment

  • Overview
  • Asia-Pacific Non-Invasive Blood Glucose Monitoring System Market Size Value (US$) and Volume (Million Tons), by Technology (2021 – 2033)
    • Spectroscopy 
    • Electromagnetic 
    • Microwave 
    • Ultrasonic 
    • Thermal 
    • Others
  • Asia-Pacific Non-Invasive Blood Glucose Monitoring System Market Size Value (US$) and Volume (Million Tons), by End User (2021 – 2033)
    • Hospitals
    • Homecare
    • Clinics
  • Asia-Pacific Non-Invasive Blood Glucose Monitoring System Market Size Value (US$) and Volume (Million Tons), by Modality (2021 – 2033)
    • Non wearable
    • Wearable
    • Invasive
    • Non-invasive
  • Asia-Pacific Non-Invasive Blood Glucose Monitoring System Market Size Value (US$) and Volume (Million Tons), by Distribution Channel (2021 – 2033)
    • Retail Sales
    • Institutional Sales

Latin America Non-Invasive Blood Glucose Monitoring System Market Assessment

  • Overview
  • Latin America Non-Invasive Blood Glucose Monitoring System Market Size Value (US$) and Volume (Million Tons), by Technology (2021 – 2033)
    • Spectroscopy 
    • Electromagnetic 
    • Microwave 
    • Ultrasonic 
    • Thermal 
    • Others
  • Latin America Non-Invasive Blood Glucose Monitoring System Market Size Value (US$) and Volume (Million Tons), by End User (2021 – 2033)
    • Hospitals
    • Homecare
    • Clinics
  • Latin America Non-Invasive Blood Glucose Monitoring System Market Size Value (US$) and Volume (Million Tons), by Modality (2021 – 2033)
    • Non wearable
    • Wearable
    • Invasive
    • Non-invasive
  • Latin America Non-Invasive Blood Glucose Monitoring System Market Size Value (US$) and Volume (Million Tons), by Distribution Channel (2021 – 2033)
    • Retail Sales
    • Institutional Sales

Middle East & Africa (MEA) Non-Invasive Blood Glucose Monitoring System Market Assessment

  • Overview
  • Middle East & Africa (MEA) Non-Invasive Blood Glucose Monitoring System Market Size Value (US$) and Volume (Million Tons), by Technology (2021 – 2033)
    • Spectroscopy 
    • Electromagnetic 
    • Microwave 
    • Ultrasonic 
    • Thermal 
    • Others
  • Middle East & Africa (MEA) Non-Invasive Blood Glucose Monitoring System Market Size Value (US$) and Volume (Million Tons), by End User (2021 – 2033)
    • Hospitals
    • Homecare
    • Clinics
  • Middle East & Africa (MEA) Non-Invasive Blood Glucose Monitoring System Market Size Value (US$) and Volume (Million Tons), by Modality (2021 – 2033)
    • Non wearable
    • Wearable
    • Invasive
    • Non-invasive
  • Middle East & Africa (MEA) Non-Invasive Blood Glucose Monitoring System Market Size Value (US$) and Volume (Million Tons), by Distribution Channel (2021 – 2033)
    • Retail Sales
    • Institutional Sales

Company Profiles

  • Abbott Laboratories
    • Company Overview
    • Geographic Footprints
    • Financial Performance
    • Product Portfolio
    • SWOT Analysis
    • R&D Efforts
    • Recent Developments & Strategic Collaborations
      • Product Launch/M&A/Technical Collaboration
  • Medtronic plc
  • F. Hoffmann-La Roche Ltd.
  • Ascensia Diabetes Care
  • DexcomInc.
  • Sanofi Novo Nordisk
  • Insulet Corporation
  • Ypsomed Holdings
  • Glysens Incorporated

Conclusion & Recommendations

  • Insight Code: 5060
  • No. of Pages: 150
  • Format: PDF/PPT/Excel
  • Published: May 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2022
  • Base Year: 2023
  • Estimated Years: 2024-2033

About The Author

Rohan Patil is a seasoned market research professional with over 5 years of focused experience in the healthcare sector, bringing deep domain expertise, strategic foresight, and analytical precision to every project he undertakes.

He began his journey with Precedence Research, where he played a pivotal role in developing high-impact healthcare market reports. Today, Rohan leads research initiatives at Towards Healthcare, while also contributing to Statifacts, where he supports cross-industry analysis and data-driven storytelling.

Rohan’s core strengths lie in trend analysis and emerging technologies, regulatory monitoring and thought leadership through high-quality report writing. He excels at identifying future-ready opportunities and translating complex data into strategic recommendations. His work spans pharmaceuticals, biotechnology, medical devices, and digital health, assessing everything from market potential and competitive positioning to customer needs and regulatory shifts.

A trusted advisor and a relentless innovator, Rohan continues to push the boundaries of traditional market research, merging scientific rigor with commercial insight to stay ahead in a fast-evolving healthcare landscape.

FAQ's

The current size of the blood glucose monitoring system market is valued at $21.76 million in 2022. The market is expected to grow at a CAGR of 25% during the forecast period, with projected revenues reaching $202.73 million by 2032.

The growth of the blood glucose monitoring system market is primarily driven by factors such as the rising prevalence of diabetes, increasing adoption of self-monitoring devices, technological advancements in glucose monitoring systems, and growing awareness about the importance of regular blood glucose monitoring.

The market for blood glucose monitoring systems varies across regions. North America and Europe currently dominate the market due to high healthcare expenditure and advanced healthcare infrastructure. However, the Asia Pacific region is expected to witness the fastest growth due to the rising diabetic population, improving healthcare infrastructure, and increasing awareness about diabetes management.